NR1I2 and tuberculosis: A recent study showed the association of polymorphisms in NR1I2 with decreased risk of RIF-based anti-TB drugs induced liver injury suggesting that drug-metabolizing enzymes regulated by PXR may be involved in the pathogenesis of anti-TB drugs induced liver injury20.